Bio-Rad Laboratories (BIO) Return on Invested Capital (2010 - 2026)

Bio-Rad Laboratories (BIO) has 17 years of Return on Invested Capital data on file, last reported at 0.0% in Q1 2026.

• On a quarterly basis, Return on Invested Capital fell 51.0% year-over-year to 0.0% in Q1 2026; TTM through Mar 2026 was 0.0%, a 51.0% decrease from a year earlier, with the FY2025 full-year figure at 0.29%, down 220.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.0%, down from 0.07% in the prior quarter.
• Over the last five years, Return on Invested Capital for BIO reached as high as 1.96% in Q4 2022 and fell as low as 0.0% in Q1 2026.
• Historically, Return on Invested Capital has averaged 0.97% across 5 years, with a median of 1.06% in 2022.
• Across the five-year window, Return on Invested Capital surged 165 bps in 2022 and plunged 96 bps in 2025, its largest moves.
• Year by year, Return on Invested Capital stood at 1.96% in 2022, then plunged by 34 bps to 1.3% in 2023, then sank by 47 bps to 0.69% in 2024, then sank by 90 bps to 0.07% in 2025, then plunged by 97 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Invested Capital figures were 0.0% in Q1 2026, 0.07% in Q4 2025, and 0.36% in Q3 2025.